Dr Reddys Q2 revenue up 26.4 pc to Rs 4801 crore Medical Dialogues Bureau3 Nov 2019 4:00 AM GMTRevenue in the second quarter stood at Rs 4,800.9 crore as against Rs 3,797.8 crore in the year-ago period, an increase of 26.41 per cent, Dr Reddy's...
Dr Reddys recalls Ranitidine products in US over cancer-causing impurity Medical Dialogues Bureau24 Oct 2019 4:00 AM GMTThis recall follows the USFDA's caution note alerting patients and healthcare professionals that NDMA was found in certain samples of ranitidine, Dr...
Dr Reddys unveils generic version of Zyban ER tablets in US Medical Dialogues Bureau5 Sep 2019 11:31 AM GMTThe company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration...
NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister Medical Dialogues Bureau24 July 2019 6:46 AM GMTNPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu Medical Dialogues Bureau20 July 2019 6:07 AM GMTIn a BSE filing, Dr Reddy's Labs(Dr Reddys) announced "launch of Fexofenadine HCI 60 mg and Pseudoephedrine HCI 120 mg extended-release tablets, USP,...
Dr Reddys unveils generic version of Vitamin K1 injection in US Medical Dialogues Bureau25 Jun 2019 5:22 AM GMTThe Vitamin K1 (Phytonadione) for Injectable Emulsion USP, 10 mg/ml brand and generic, had combined US sales of approximately USD 46.6 million MAT for...
Dr Reddys gets two USFDA observations for Vizag plants Farhat Nasim24 Jun 2019 5:39 AM GMTHyderabad: City-based Dr Reddy's Laboratories (Dr Reddys/ DRL) has reportedly fallen under the US health regulator's scanner. The company has been...
Dr Reddy's launches Tadalafil Tablets to treat erectile dysfunction Farhat Nasim28 March 2019 6:36 AM GMTDr Reddy's Tadalafil tablets are available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in 30-count bottle size.New Delhi: Dr...
USFDA completes audit for Dr Reddys Shreveport plant, no observations issued Medical Dialogues Bureau23 Feb 2019 4:00 AM GMT"The audit of our formulations Shreveport plant, Louisiana, USA, by the United States Food and Drug Administration (USFDA) has been completed with...
Dr Reddy's gets four observations from USFDA for Andhra plant Medical Dialogues Bureau19 Jan 2019 4:00 AM GMT"The audit of our formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US Food and Drug Administration (USFDA), has been completed today....
Dr Reddy's gets nod to restart exports to EU from Vizag plant Ruby Khatun Khatun2 Dec 2017 5:00 AM GMTNew Delhi: Dr. Reddy's Laboratories said a German regulatory authority has allowed company's Visakhapatnam-based plant to restart production for the...
Securities class action lawsuit served on Dr Reddys in US Ruby Khatun Khatun1 Dec 2017 5:11 AM GMTNew Delhi: Drug firm Dr. Reddy's Laboratories on Wednesday said it has been served a securities class action lawsuit in the US for alleged violations...
